对比剂肾病预测模型在EVAR中的验证
该回顾性研究纳入216例EVAR患者,验证8个CIN预测模型。急性肾损伤发生率24小时为8%,48小时为12%,72小时为11%,随访时为6%。8个模型C统计量0.61-0.75(P=.026至P<.001),5个模型区分能力良好(C>0.70),Mehran和Tziakas模型C统计量最高为0.75(P<.001)。
要点
- 5个CIN预测模型在EVAR患者中区分能力良好(C统计量>0.70)。
- Mehran和Tziakas模型C统计量最高,为0.75(P<.001)。
- EVAR术后48小时急性肾损伤发生率最高,为12%。
核心结论
- 文献中12个CIN预测模型有8个适用于EVAR患者验证,其中5个能有效识别CIN风险患者。
研究设计与样本
- 回顾性研究,纳入2008年1月至2015年12月期间接受EVAR的216例患者。
- 评估术后24、48、72小时及随访时的急性肾损伤发生率,采用C统计量验证8个CIN预测模型。
主要发现
- 患者平均年龄73岁,162例(75%)为择期手术。
- 术前慢性肾脏病1至5期比例分别为16%、42%、31%、6%、5%;术中平均对比剂用量280 mL。
- 急性肾损伤发生率24小时为8%,48小时为12%,72小时为11%,随访时为6%;3%患者转为透析依赖。
- 8个模型C统计量为0.61至0.75(P=.026至P<.001);5个模型C统计量>0.70,Mehran和Tziakas模型最高为0.75(P<.001)。
临床怎么用
- 在EVAR患者中可选用区分能力良好的CIN预测模型(如Mehran或Tziakas模型)识别高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Existing risk prediction models for contrast-induced nephropathy (CIN) are based on studies for percutaneous coronary interventions, with none validated for use in vascular procedures. We aim to validate existing CIN prediction models in patients who underwent aortic endovascular aneurysm repair (EVAR). METHODS: A retrospective review of 216 patients who underwent EVAR between January 2008 and December 2015 was undertaken. Incidence of acute kidney injuries at 24, 48, and 72 hours and at follow-up were evaluated. Of 12 CIN prediction models within the literature, 8 were suitable for validation in patients who underwent EVAR and validation was performed with C-statistics. RESULTS: There were 216 EVARs performed within the study period. The mean patients age was 73 years and 162 (75%) were performed in an elective setting. Percentage of preoperative chronic kidney disease stages 1 to 5 were 16%, 42%, 31%, 6%, and 5%, respectively. The mean intraprocedure contrast volume used was 280 mL. Incidence of acute kidney injuries at 24, 48, and 72 hours and at follow-up were 8%, 12%, 11%, and 6%, respectively. Three percent of patients became dialysis dependent. Validation of the eight existing CIN predication models reveal area under curve C-statistics between 0.61 and 0.75 (P = .026 to P < .001). Five of the 8 had good discriminative ability (C-statistics of >0.70) and the CIN prediction models by Mehran and Tziakas had the highest C-statistics at 0.75 (P < .001). CONCLUSIONS: In our study population, 8 of 12 CIN prediction models within the literature were validated for use in patients undergoing EVAR and five are useful in identifying patients at risk for CIN.
引用
- Cheng EL, Hong Q, Yong E, et al. Validating the use of contrast-induced nephropathy prediction models in endovascular aneurysm repairs. J Vasc Surg. 2019. PMID: 31648760. doi:10.1016/j.jvs.2019.07.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。